13F-HR filed by DIADEMA PARTNERS LP
DIADEMA PARTNERS LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 15:31:07 UTC, with 148 holding rows worth $780,451,639.
- Accession
- 0001892688-26-000170
- Filer
- CIK 2026172
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 148 entries on the cover page, a total value of $780,451,639 stated on the cover page (in dollars after the unit check, H1), rows summing to $780,451,639 with VALUE read as dollars as filed, 13F file number 028-25172. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,361,900 | $44,397,940 | dollars as filed | put |
| Bristol-Myers Squibb Company | 110122108 | COM | 600,000 | $37,440,000 | dollars as filed | call |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,139,400 | $37,144,440 | dollars as filed | call |
| VIKING THERAPEUTICS INC | 92686JAA4 | NOTE 2.000%10/1 | 1,000,000 | $32,600,000 | dollars as filed | principal |
| KODIAK SCIENCES INC | 50015M109 | COM | 297,000 | $28,155,600 | dollars as filed | put |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 47,500 | $25,739,775 | dollars as filed | call |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 46,222 | $25,047,240 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 250,000 | $24,575,000 | dollars as filed | call |
| KODIAK SCIENCES INC | 50015M109 | COM | 251,700 | $23,861,160 | dollars as filed | call |
| Bristol-Myers Squibb Company | 110122108 | COM | 330,600 | $20,629,440 | dollars as filed | put |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 641,947 | $20,555,143 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 518,100 | $18,483,218 | dollars as filed | call |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 160,900 | $17,987,011 | dollars as filed | call |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 178,444 | $17,746,445 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAJ1 | NOTE 1.750% 3/0 | 250,000 | $16,450,000 | dollars as filed | principal |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 960,200 | $16,236,982 | dollars as filed | call |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 255,383 | $15,322,980 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 70,004 | $14,369,021 | dollars as filed | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 100,000 | $14,257,000 | dollars as filed | put |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 433,166 | $14,121,212 | dollars as filed | |
| GRAIL INC | 384747101 | COM | 100,000 | $14,012,000 | dollars as filed | call |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 137,700 | $13,635,054 | dollars as filed | put |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 801,400 | $13,551,674 | dollars as filed | put |
| INCYTE CORP COM | 45337C102 | Stock | 105,400 | $12,790,290 | dollars as filed | put |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 100,000 | $11,523,000 | dollars as filed | call |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 114,600 | $11,347,692 | dollars as filed | call |
| VAXCYTE INC COM | 92243G108 | Stock | 197,800 | $11,254,820 | dollars as filed | put |
| VAXCYTE INC COM | 92243G108 | Stock | 153,100 | $8,711,390 | dollars as filed | call |
| MODERNA INC | 60770K107 | COM | 44,400 | $8,550,108 | dollars as filed | call |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 50,000 | $7,884,000 | dollars as filed | put |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 257,200 | $7,782,872 | dollars as filed | call |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 103,960 | $6,840,568 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 221,764 | $6,717,232 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 421,107 | $6,026,041 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 235,400 | $5,687,264 | dollars as filed | call |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 800,000 | $5,456,000 | dollars as filed | call |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 257,076 | $5,293,195 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 199,300 | $4,815,088 | dollars as filed | put |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 497,300 | $4,709,431 | dollars as filed | call |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 484,400 | $4,587,268 | dollars as filed | put |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 150,000 | $4,539,000 | dollars as filed | put |
| Johnson & Johnson | 478160104 | COM | 17,000 | $4,500,580 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 317,000 | $4,231,950 | dollars as filed | call |
| INDIVIOR PHARMACEUTICALS INC | 45579U109 | COM | 117,512 | $4,212,805 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 72,850 | $4,145,165 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 305,000 | $4,038,200 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 153,810 | $3,972,912 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 200,000 | $3,816,000 | dollars as filed | call |
| KODIAK SCIENCES INC | 50015M109 | COM | 38,991 | $3,696,347 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 120,000 | $3,631,200 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 60,000 | $3,517,200 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 304,200 | $3,276,234 | dollars as filed | call |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 124,100 | $3,205,503 | dollars as filed | call |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 100,000 | $3,202,000 | dollars as filed | call |
| PHARVARIS NV | N69605108 | COMMON STOCK | 100,000 | $3,172,000 | dollars as filed | put |
| SELLAS LIFE SCIENCES GROUP I | 81642T209 | COM NEW | 250,000 | $3,077,500 | dollars as filed | put |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 100,000 | $3,029,000 | dollars as filed | call |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 200,000 | $2,964,000 | dollars as filed | call |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 30,000 | $2,856,450 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 90,000 | $2,854,800 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 181,947 | $2,789,248 | dollars as filed | |
| SELLAS LIFE SCIENCES GROUP I | 81642T209 | COM NEW | 200,000 | $2,462,000 | dollars as filed | call |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 200,000 | $2,412,000 | dollars as filed | call |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 204,811 | $2,359,423 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 604,025 | $2,355,698 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 18,497 | $2,111,248 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 250,000 | $2,082,500 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 553,126 | $2,064,403 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 422,619 | $2,058,155 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 200,000 | $2,006,000 | dollars as filed | call |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 40,435 | $1,964,332 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 44,346 | $1,800,448 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 208,167 | $1,744,439 | dollars as filed | |
| PELTHOS THERAPEUTICS INC | 171126204 | COM SHS | 80,760 | $1,696,768 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 200,000 | $1,610,000 | dollars as filed | call |
| CELCUITY INC | 15102K100 | COM | 20,000 | $1,590,400 | dollars as filed | call |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 53,152 | $1,546,723 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 133,400 | $1,536,768 | dollars as filed | call |
| ALUMIS INC | 022307102 | COM | 200,000 | $1,478,000 | dollars as filed | call |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 398,869 | $1,467,838 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 100,000 | $1,459,000 | dollars as filed | call |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 826,286 | $1,371,635 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 361,367 | $1,362,354 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 50,000 | $1,321,500 | dollars as filed | call |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 179,950 | $1,313,635 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 91,259 | $1,282,189 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 50,000 | $1,256,500 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 38,008 | $1,227,278 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 100,000 | $1,170,000 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 13,169 | $1,096,846 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 400,000 | $1,028,000 | dollars as filed | call |
| MACROGENICS INC | 556099109 | COM | 262,059 | $1,011,548 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 70,000 | $939,400 | dollars as filed | call |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 192,600 | $904,257 | dollars as filed | call |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 35,271 | $873,522 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 64,549 | $866,248 | dollars as filed | |
| ADIAL PHARMACEUTICALS INC | 00688A304 | COM NEW | 181,890 | $729,379 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 245,098 | $713,235 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 41,887 | $708,309 | dollars as filed | |
| NOVABRIDGE BIOSCIENCES | 44975P103 | CMN | 500,000 | $682,500 | dollars as filed | |
| QUOIN PHARMACEUTICALS LTD | 74907L409 | SPONSORED ADS | 146,446 | $667,794 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 30,000 | $656,100 | dollars as filed | put |
| KARDIGAN INC | 485925101 | CMN | 43,972 | $648,587 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 100,000 | $635,000 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 25,000 | $623,750 | dollars as filed | |
| SELLAS LIFE SCIENCES GROUP I | 81642T209 | COM NEW | 50,000 | $615,500 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 185,705 | $593,327 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 135,000 | $540,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 21,539 | $510,690 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 133,385 | $493,525 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 10,000 | $458,400 | dollars as filed | |
| TALPHERA INC | 00444T209 | COM NEW | 378,037 | $438,523 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 150,000 | $402,000 | dollars as filed | call |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 102,500 | $399,750 | dollars as filed | call |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 10,000 | $371,900 | dollars as filed | |
| INOVIO PHARMACEUTICALS I | 45773H409 | COMMON STOCK | 275,200 | $335,744 | dollars as filed | call |
| AETHLON MEDICAL INC | 00808Y703 | Common Stock, $0.001 par value per share | 50,000 | $326,000 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 51,117 | $268,364 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 77,133 | $263,795 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 50,000 | $211,500 | dollars as filed | call |
| OCUGEN INC | 67577C105 | COMMON STOCK | 200,000 | $206,000 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 88,200 | $205,506 | dollars as filed | call |
| GAIN THERAPEUTICS INC | 36269B105 | COM | 108,200 | $187,186 | dollars as filed | call |
| Elicio Therapeutics Inc Com | 28657F103 | LST Equity Option | 100,000 | $182,000 | dollars as filed | put |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 9,700 | $166,258 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 17,587 | $154,414 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 458,723 | $143,810 | dollars as filed | |
| AYTU BIOPHARMA INC | 054754858 | COM | 67,186 | $143,778 | dollars as filed | |
| JATT II ACQUISITION CORP | G50765109 | ORD SHS | 12,174 | $136,897 | dollars as filed | |
| CELLECTAR BIOSCIENCES INC | 15117F880 | COM NEW | 71,382 | $131,343 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 88,500 | $108,855 | dollars as filed | call |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 69,533 | $93,870 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 3,400 | $82,144 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 5,503 | $72,530 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 60 | $69,425 | dollars as filed | |
| TVARDI THERAPEUTICS INC | 140755307 | COM | 48,491 | $60,614 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 50,000 | $52,000 | dollars as filed | call |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 28,872 | $21,654 | dollars as filed | |
| OUTLOOK THERAPEUTICS INC | 69012T305 | COM | 35,000 | $20,073 | dollars as filed | |
| Elicio Therapeutics Inc Com | 28657F103 | LST Equity Option | 9,440 | $17,181 | dollars as filed | |
| Elicio Therapeutics Inc Com | 28657F103 | LST Equity Option | 6,500 | $11,830 | dollars as filed | call |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 194 | $11,322 | dollars as filed | |
| MAXCYTE INC | 57777K106 | COM | 8,190 | $9,173 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 500 | $5,500 | dollars as filed | call |
| ATYR PHARMA INC | 002120202 | COM NEW | 12,500 | $3,788 | dollars as filed | put |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 1,046 | $2,930 | dollars as filed | put |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 200 | $2,648 | dollars as filed | put |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 124 | $1,495 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001892688-26-000170 | this filing | 2026-11-16 |